10 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 14 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 10, Active not recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 4 | Completed 1, Recruiting 1, Terminated 1, Withdrawn 1 |
Follow Zofran: new trials by email Literature Review of Zofran trials Research Report on Zofran
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy of B6 and Metoclopramide Combination in Comparison With the Other Antiemetics Metoclopramide and Vitamin B6, Vitamin B6, Ondansetron - Vomiting | Phase 2 / Phase 3 | Completed | University of Baghdad | 250 | 2024-01-30 | 2024-04-30 |
| Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy Ondansetron 8mg, Gabapentin - Post Operative Nausea and Vomiting, Sleeve Gastrectomy | Phase 3 | Completed | Tanta University | 100 | 2022-10-01 | 2025-04-17 |
| Inhaled Isopropyl Alcohol for Treatment of Nausea Inhaled Isopropyl Alcohol, Oral Ondansetron, Inhaled Placebo - Vomiting, Nausea | Phase 2 / Phase 3 | Recruiting | State University of New York at Buffalo | 84 | 2022-04-20 | 2026-09-24 |
| Cisplatin Disposition and Kidney Injury Granisetron, Ondansetron, Palonosetron - Nephrotoxicity | Phase 3 | Active not recruiting | University of Colorado, Denver | 45 | 2019-11-15 | 2026-09-17 |
| Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Ondansetron Oral Solution, Oral Placebo - Acute Gastroenteritis, Viral Illness | Phase 3 | Completed | University of Calgary | 1030 | 2019-09-14 | 2025-04-25 |
| Triage Administration of Ondansetron for Gastroenteritis in Children Ondansetron, Placebos - Gastroenteritis | Phase 2 / Phase 3 | Terminated | St. Justine's Hospital | 81 | 2017-07-15 | 2020-10-22 |
| Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA Transversus Abdominis Plane (TAP) block, Nimbus Infusion Pump IV Administration, Bupivacaine infusion - Breast - Female | Phase 3 | Completed | Stanford University | 120 | 2015-11-01 | 2021-09-23 |
| Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) Fosaprepitant dimeglumine, Fosaprepitant Placebo, Dexamethasone - Chemotherapy-Induced Nausea and Vomiting (CINV) | Phase 3 | Completed | Merck Sharp & Dohme LLC | 1015 | 2012-09-24 | 2018-09-04 |
| Pharmacogenetic Treatments for Alcoholism Ondansetron + Brief Behavioral Enhancement Treatment, Placebo + Brief Behavioral Enhancement Treatment - Alcoholism | Phase 2 / Phase 3 | Withdrawn | University of Virginia | 2012-06-01 | 2023-04-20 | |
| Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation Granisetron, Ondansetron, Questionnaires - Cancer of the Cervix | Phase 3 | Completed | M.D. Anderson Cancer Center | 76 | 2012-03-01 | 2021-06-11 |
| Symptomatic Treatment of Acute Gastroenteritis Ondansetron, Domperidone, placebo - Gastroenteritis, Vomiting | Phase 3 | Completed | IRCCS Burlo Garofolo | 356 | 2011-07-01 | 2014-04-21 |
| Combined Pharmacotherapies for Alcoholism Ondansetron 4 ug/kg b.i.d. + Cognitive Behavioral Therapy, Naltrexone 50 mg/day + Cognitive Behavioral Therapy, Ondansetron 4 ug/kg b.i.d.+ Naltrexone 50 mg/day + Cognitive Behavioral Therapy - Alcoholism | Phase 3 | Completed | Bankole Johnson | 300 | 2008-09-01 | 2013-03-15 |
| Pharmacological Treatment for Alcoholism Ondansetron + Cognitive Behavioral Therapy, Placebo + Cognitive Behavioral Therapy - Alcohol Dependence | Phase 3 | Completed | Bankole Johnson | 283 | 2006-06-01 | 2012-02-07 |
| A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015) Comparator: MK0517, Comparator: ondansetron - Post-Operative Nausea and Vomiting | Phase 3 | Completed | Merck Sharp & Dohme LLC | 216 | 2005-07-01 | 2015-08-19 |
Vomiting (8) · Alcoholism (3) · Gastroenteritis (3) · Nausea (2) · Diarrhea (1) · Emergencies (1) · Obesity, Morbid (1) · Postoperative Nausea and Vomiting (1) · Uterine Cervical Neoplasms (1) · Virus Diseases (1)
Bankole Johnson (2) · Merck Sharp & Dohme LLC (2) · IRCCS Burlo Garofolo (1) · M.D. Anderson Cancer Center (1) · St. Justine's Hospital (1) · Stanford University (1) · State University of New York at Buffalo (1) · Tanta University (1) · University of Baghdad (1) · University of Calgary (1) · University of Colorado, Denver (1) · University of Virginia (1)
United States (7) · Canada (2) · Egypt (1) · Iraq (1) · Italy (1)
Alana Koehler, MD (1) · Bankole Johnson, DSc, MD, PhD (1) · Bankole Johnson, DSc,MD,PhD (1) · Bankole Johnson, M.D., Ph.D. (1) · Edgar Jaimes, MD (1) · Federico Marchetti, MD (1) · Gordon K Lee, MD (1) · Hashim Talib T Hashim, MBChB (1) · Heather Territo, MD (1) · Jocelyn Gravel, MD (1) · Maurizio Bonati, MD (1) · Melanie Joy, PharmD, PhD (1) · Michael M. Frumovitz, MD, MPH (1)
PMID 23897038, PMID 26449391, PMID 29808377, PMID 32460879, PMID 32838813, PMID 32988373, PMID 38955285, PMID 39711135, PMID 39726772, PMID 40673584, PMID 42090154, PMID 42637866, PMID 42782131
R01AA010522 (1), R01AA012964 (1), R01GM123330 (1)